Articles
Cell-specific Mathematical Modelling of hiPSC-CMs and Its Potential for Prediction of Drug Testing
Citation:
European Cardiology Review 2018;13(2):131.
Early, Optimal Blood Pressure Control for High-risk Patients
Citation:
European Cardiovascular Disease 2006;2(1):1–5
Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis
Citation:
European Cardiology Review 2020;15:e37.
Non-invasive Risk Stratification Early After a Myocardial Infarction - The Risk Estimation Following Infarction Non-invasive Evaluation (REFINE) Study
Citation:
European Cardiology 2008;4(1):21–2
Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
Published:
18 December 2019
Citation:
European Cardiology Review 2019;14(3):201
Analysis of the Effects of EPA and DHA on Cardiomyocyte hypertrophy
Citation:
European Cardiology Review 2018;13(2):121.
Magnetic Resonance Angiography Using the Intravascular Contrast Agent Vasovist®
Citation:
European Cardiovascular Disease 2006;2(1):49–52
Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome
Citation:
European Cardiology Review 2020;15:e27.
The Mechanism of Hey2 Expression in Cardiac Development
Citation:
European Cardiology Review 2018;13(2):128.